Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 22, 2025Frontiers in OncologyOpen Access

Preoperative radiotherapy in patients with locally advanced esophageal squamous cell carcinoma: a narrative review

View Full Paper
Ask AI
Bookmark
Share

Authors

YLYan LinSWShoufeng WangHLHuan-Wei Liang

Discussion

Loading...

Member takes

Overview

Narrative review highlights neoadjuvant treatments and survival outcomes in patients with esophageal cancer, indicating importance of ongoing trials.

Key Points

  • Neoadjuvant treatments significantly improve survival rates in patients with locally advanced esophageal squamous cell carcinoma.
  • CROSS and NEOCRTEC5010 trials report enhanced survival with neoadjuvant chemoradiotherapy over surgery alone.
  • Recent trials show neoadjuvant triplet chemotherapy offers statistically significant overall survival benefits. Neoadjuvant immunotherapy exhibits higher histological complete response rates than chemotherapy.
  • Ongoing research is essential to clarify the role of radiotherapy and establish definitive treatment protocols as techniques evolve.

Cite This Study

Lin et al. (2025) studied this question.

synapsesocial.com/papers/689a0614e6551bb0af8cd73ehttps://doi.org/10.3389/fonc.2025.1613954
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Editorial: The role of adjuvant and neoadjuvant therapy in resectable esophageal cancer2025
  2. 2Esophageal Cancer – Finally a Light at the End of the Tunnel?2025
  3. 3780. NEOADJUVANT IMMUNOTHERAPY COMBINED WITH CHEMORADIOTHERAPY VS NEOADJUVANT CHEMORADIOTHERAPY FOR LOCALLY ADVANCED ESOPHAGEAL CARCINOMA (CSTAGEII-III): A MULTI-CENTER PROSPECTIVE RANDOMIZED CLINICAL TRIAL (ICROSS)2024
  4. 4Neoadjuvant Chemoradiation versus Perioperative Chemotherapy in Locally Advanced Resectable Esophageal Adenocarcinoma: A National Analysis.2026 · 2 citations
  5. 5Case report: A case study of neoadjuvant immunochemotherapy for locally advanced esophageal squamous carcinoma2024 · 1 citations